Prognosis of ALS: Comparing data from the Limousin referral centre, France, and a Uruguayan population

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 5-6, 2009, Pages 355-360

  Gil, Juan ^a,d,e   Vazquez, Maria C ^e   Ketzoian, Carlos ^d,e   Perna, Abayuba ^e   Marin, Benoit ^a,b,c   Preux, Pierre Marie ^a,b,c   Couratier, Philippe ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^e Neuroepidemiology Section   (Uruguay)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Survival

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FRANCE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SEX RATIO; SURVIVAL; SURVIVAL TIME; URUGUAY;

AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; POPULATION GROUPS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SURVIVAL RATE; URUGUAY;

EID: 70450160997     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960902748686     Document Type: Article

References (35)

1. Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A; SLALOM GROUP. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:163-7.
2. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33-7.
3. O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30-2.
4. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population based registry. Neuroepidemiology. 2005;25:114-9.
5. Forbes RB, Colville S, Cran GW, Swingler RJ. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neuron disease J Neurol Neurosurg Psychiatry. 2004;75: 1753-5.
6. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813-9.
7. Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population based study. Neurology. 2002;59:99-103. (Pubitemid 34742801)
8. Tysnes OB, Vollset SE, Larsen JP, Aarli JA. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994;13:226-35.
9. Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology. 1990;40:600-4.
10. Gil J, Preux PM, Alioum A, Ketzoian C, Desport JC, Druet-Cabanac M, et al. Disease progression and survival in ALS: first multi-state model approach. Amyotroph Lateral Scler. 2007;8:224-9.
11. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006;253:1428-36.
12. Thijs V, Peeters E, Theys P, Matthijs G, Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg. 2000;100:84-90.
13. Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci. 1997;152(Suppl 1):S10-7.
14. Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996;15: 153-60.
15. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707-19.
16. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993;16:27-32. (Pubitemid 23014301)
17. Werneck LC, Bezerra R, Silveira Neto O, Scola RH. A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Arq Neuropsiquiatr. 2007;65:189-95.
18. Castro-Costa CM, Oriá RB, Vale OC, Arruda JA, Horta WG, D'Almeida JA, et al. Motor neuron diseases in the university hospital of Fortaleza (north-eastern Brazil): a clinico-demographic analysis of 87 cases. Arq Neuropsiquiatr. 2000;58:986-9.
19. Dietrich-Neto F, Callegaro D, Dias-Tosta E, Silva HA, Ferraz ME, Lima JM, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr. 2000;58: 607-15.
20. Dubrovsky AL, Sica RE. Current treatment pathways in ALS: a South American perspective. Neurology. 1999;53: S11-6.
21. Galdames D, Aguilera L, Riveros JM, Arce C. Epidemiology of amyotrophic lateral sclerosis in Santiago. A retrospective study. Rev Med Chil. 1980;108:435-9.
22. Vázquez MC, Ketzoian C, Legnani C, Rega I, Sánchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in UY: a population based study. Neuroepidemiology. 2008;30:105-11.
23. Chiò A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol. 1999;246(Suppl 3):1-5.
24. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995;132:207-15.
25. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study,1996-2000. J Neurol Neurosurg Psychiatry. 2003;74: 1258-61.
26. Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G; PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948-50.
27. Instituto Nacional de Estad?́stica (INE): Anuario estad?́stico 2005. Montevideo, INE, 2005. Available at http://www.ine. gub.uy/
28. Institut Nationale de la Statistique et des Etudes Economiques (INSEE). Available at http://www.insee.fr/
29. Observatoire Régionale de la Santé du LIM: Chiffres clés. Available at http://www.ors-LIM.org/
30. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases /Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci. 1994;124(Suppl): 96-107.
31. Aid to the investigation of peripheral nerve injuries. In: Medical Research Council, ed. War memorandum, 2nd edn., revised. London: His Majesty's Stationery Office 1943:11-46.
32. ALS CNTF Treatment Study Phase I-II Group, Brooks BR, Sanjak M, Ringel S, England J, Brinkmann J, et al. The ALS functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141-7.
33. Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Marcharia W, Dumas M. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000;53: 1025-9.
34. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted, Minnesota, 1925 to 1998. Neurology. 2002;59:280-2.
35. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival. Results from a population based study in southern Italy. J Neurol. 2007;254:1107-12.